RBC Capital analyst Sean Dodge raised the firm’s price target on HealthEquity to $90 from $77 and keeps an Outperform rating on the shares after its 3-year outlook update. The company has steadily grown into a premier healthcare consumer empowerment platform, and the firm sees a significant remaining opportunity for HealthEquity just by doing “more of the same”, the analyst tells investors in a research note.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on HQY:
- HealthEquity Reports Year-End Sales Metrics
- HealthEquity price target raised to $93 from $85 at BofA
- HealthEquity Recognized by Glassdoor as a Top U.S. Workplace for 2024
- Wells says key metrics tracking ahead as HealthEquity provides sales outlook
- HealthEquity Announces Year-End HSA Sales Outlook; Presentation at J.P. Morgan Healthcare Conference; Investor Day
